PRP and Stem Cell Therapy for Pain: What the Evidence Shows
Platelet-rich plasma and stem cell injections are marketed heavily for joint and tendon pain. This guide separates what the evidence supports from what it does not, and explains costs, risks, and regulatory status.
Analyzed Article
This fact-check analysis pertains to a specific external article.
Title: Chronic pain (primary and secondary) in over 16s: assessment and management (NG193) ( Read original article )
Source: National Institute for Health and Care Excellence
Claim-by-Claim Ledger
| ID | Claim | Risk | Verdict | Evidence | Notes |
|---|---|---|---|---|---|
| C1 | Platelet-rich plasma is prepared by concentrating a patient's own platelets from their blood and injecting them into the painful tissue. | low | supported | V1 | Preparation methods vary widely between clinics. |
| C2 | Evidence for PRP is mixed and strongest for knee osteoarthritis and certain tendinopathies, while preparation and protocol variability limits firm conclusions. | high | partial | V1, V3 | Trials differ in platelet concentration, leukocyte content, and injection number. |
| C3 | Stem cell injections for musculoskeletal pain remain investigational, and clinics marketing them often use products that are not approved for these uses. | high | supported | V1 | Patients should verify regulatory status and trial enrolment. |
| C4 | Regenerative injections do not replace exercise therapy and weight management as core treatment for osteoarthritis. | high | supported | V2, S2 | Core treatments have far stronger evidence. |
What PRP and stem cell therapy for pain involve
Platelet-rich plasma (PRP) is made by drawing your blood, spinning it to concentrate platelets, and injecting that concentrate into a painful joint or tendon, with the aim of delivering growth factors that support tissue repair [V1]. Stem cell treatments — usually bone marrow aspirate concentrate or adipose-derived preparations — aim to do something similar with cells rather than platelets. The honest summary in 2026: PRP has genuine but mixed evidence in specific conditions, and stem cell therapy for musculoskeletal pain remains investigational [V1].
Key numbers
- 4–12 weeks: usual time to see benefit after PRP, with peak effect often at 3 to 6 months [V1].
- A few days: expected period of increased soreness after injection [V1].
- Highly variable: platelet concentration, leukocyte content, and number of injections differ between studies and clinics, which is the main reason evidence is inconsistent [V1].
- Usually self-funded: PRP and stem cell injections are rarely covered by insurance for musculoskeletal pain.
Where the evidence is strongest, and weakest
| Condition | Evidence for PRP | Practical position |
|---|---|---|
| Knee osteoarthritis | Moderate, mixed; several positive trials | Reasonable option after core treatment fails [V1][V2] |
| Lateral elbow tendinopathy | Moderate | Considered for persistent cases [V3] |
| Patellar / Achilles tendinopathy | Mixed | Loading programs remain first-line [V3] |
| Rotator cuff tendinopathy | Mixed, limited | Exercise therapy first |
| Plantar fasciitis | Mixed | After stretching, loading, and shockwave [V1] |
| Spinal disc and facet pain | Early, limited | Investigational |
| Stem cells, any of the above | Investigational | Ask about trial enrolment and regulatory status [V1] |
What it is like to have PRP
Blood is drawn, usually 15 to 60 mL, and spun for around 10 to 15 minutes. The concentrate is injected, ideally under ultrasound guidance for accuracy. Anti-inflammatory medication is generally paused before and after, because the intended mechanism is an inflammatory healing response. Expect soreness for a few days, then gradual improvement over 4 to 12 weeks [V1]. Many protocols use two or three injections spaced weeks apart, which multiplies the cost.
Questions to ask before paying
- What exactly is being injected, and how is it prepared?
- Is the injection image-guided?
- What is the total cost including all sessions and follow-up?
- What proportion of your patients with my condition report meaningful improvement, and how is that measured?
- For stem cells: what regulatory approval covers this use, and is this part of a registered clinical trial [V1]?
A clinic that cannot answer these plainly is a reason for caution. Be especially wary of claims that an injection regrows cartilage, cures arthritis, or avoids the need for joint replacement — those claims outrun the evidence [V1][S2].
Do the core treatments first
For osteoarthritis, exercise, strengthening, and weight management have far stronger evidence than any injection, and they remain the foundation regardless of what else is added [V2][S2]. For tendinopathy, progressive loading programs are first-line [V3]. National guidance on chronic pain also emphasises exercise, psychological therapies, and careful drug selection over procedures with thin evidence [S1]. Our guides to arthritis pain management and knee osteoarthritis injection options cover these steps.
Risks
PRP uses your own blood, so immune reaction risk is minimal, but injection risks remain: infection, bleeding, a post-injection pain flare, and, in tendon injections, discomfort lasting weeks [V1]. Contraindications include active infection, low platelets or clotting disorders, and active malignancy. Stem cell products carry additional risks depending on source and processing, including serious adverse events reported with unapproved products, which is why regulatory status matters.
Red flags requiring urgent care
After any injection, seek prompt care for fever, spreading redness or warmth at the site, severe or escalating pain beyond the expected few days of soreness, a hot swollen joint, or pus-like discharge — these suggest infection [V1]. New numbness, weakness, or loss of function in the limb also needs same-day assessment.
Why the evidence is so inconsistent
PRP is not one treatment. Preparations differ in platelet concentration, whether white cells are included, whether the platelets are activated, injection volume, image guidance, and the number and spacing of sessions [V1]. Two trials labelled “PRP for knee osteoarthritis” can therefore test quite different products. Add small sample sizes, strong placebo responses to any injection procedure, and inconsistent outcome measures, and you get exactly the mixed literature that exists. That is a reason for calibrated expectations rather than blanket dismissal — and a reason to ask a clinic precisely what they inject and why.
Deciding whether it is worth trying
A reasonable case for PRP looks like this: a specific diagnosis such as knee osteoarthritis or lateral elbow tendinopathy, a genuine trial of core treatment — progressive loading, strengthening, weight management — already completed, a symptomatic joint that is not yet a surgical candidate, a clear total cost you are willing to self-fund, and an image-guided injection by an experienced clinician [V1][V2][S2]. A poor case looks like this: a vague diagnosis, no prior rehabilitation, a package of six sessions sold upfront, and marketing claims about regrowing cartilage or curing arthritis. Chronic pain guidance is clear that exercise and psychologically informed care carry stronger evidence than procedures with thin data [S1].
Related reading: plantar fasciitis treatment and shoulder pain treatment.
Frequently asked questions
Does PRP actually work for pain?
Sometimes, and the evidence is mixed rather than absent. The best-supported uses are knee osteoarthritis and some tendinopathies such as lateral elbow and patellar tendinopathy, where trials show pain reduction in a proportion of patients [V1][V3]. Trials vary widely in preparation method, which is why guidelines remain cautious.
How long does it take for PRP to work?
Expect a temporary increase in soreness for a few days after injection, then gradual improvement over 4 to 12 weeks, with peak effect commonly reported at around 3 to 6 months [V1]. It is not an immediate pain relief procedure, unlike a steroid injection, and often requires more than one treatment.
Is stem cell therapy for joint pain approved?
For musculoskeletal pain it is still investigational in most jurisdictions, and many clinics offering it use products that have not been approved for those uses [V1]. Ask specifically what cells are being used, what regulatory clearance applies, whether it is part of a registered trial, and what the total cost is.
Is PRP better than a cortisone injection?
They do different jobs. Steroid gives faster, shorter relief and is well established. PRP acts more slowly, and some knee osteoarthritis trials suggest longer-lasting benefit in responders [V1][V2]. Steroid is cheaper and usually covered by insurance; PRP is typically self-funded.
Who should not have PRP?
People with active infection, blood-borne infection at the site, low platelet counts or clotting disorders, active malignancy, or those unable to pause anticoagulation safely should not have PRP without specialist review [V1]. It is also the wrong choice if core treatments — strengthening, weight management, and load change — have not been tried properly [S2].
References
- [V1] Sabeh KG, et al. Regenerative Therapy in Pain. StatPearls, NCBI Bookshelf. 2026. Source . Accessed 2026-08-03.
- [V2] Sen R, Hurley JA. Primary Osteoarthritis. StatPearls, NCBI Bookshelf. 2026. Source . Accessed 2026-08-03.
- [V3] Schmitt SK, et al. Enthesopathies. StatPearls, NCBI Bookshelf. 2026. Source . Accessed 2026-08-03.
- [S1] National Institute for Health and Care Excellence. Chronic pain (primary and secondary) in over 16s: assessment and management (NG193). NICE Guidance. 2021. Source . Accessed 2026-08-03.
- [S2] National Institute of Arthritis and Musculoskeletal and Skin Diseases. Osteoarthritis health topic. NIAMS. 2026. Source . Accessed 2026-08-03.
Editorial Notes
Educational review only. This content is not personalized medical advice, diagnosis, or treatment.
Explore More In This Topic
Looking for additional coverage in this category? Browse all Regenerative Pain Treatments fact checks.